Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Clinical trial NCT07609940 · RECRUITING
Trial details
- NCT number
- NCT07609940
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2027-10-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.